129 related articles for article (PubMed ID: 11699553)
1. Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas.
Reis RM; Hara A; Kleihues P; Ohgaki H
Acta Neuropathol; 2001 Nov; 102(5):422-5. PubMed ID: 11699553
[TBL] [Abstract][Full Text] [Related]
2. Role of gemistocytes in astrocytoma progression.
Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
[TBL] [Abstract][Full Text] [Related]
3. p53 and PTEN gene mutations in gemistocytic astrocytomas.
Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
[TBL] [Abstract][Full Text] [Related]
4. Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations--a study of 32 cases.
Avninder S; Sharma MC; Deb P; Mehta VS; Karak AK; Mahapatra AK; Sarkar C
J Neurooncol; 2006 Jun; 78(2):123-7. PubMed ID: 16614946
[TBL] [Abstract][Full Text] [Related]
5. [Fraction of gemistocytic astrocytes and immunoexpression of p53 protein in astrocytomas grade II and III (WHO)].
Martins DC; Stávale JN; Malheiros SM; Santiago LH; Roman LC; Aguiar KC
Arq Neuropsiquiatr; 2001 Dec; 59(4):926-31. PubMed ID: 11733839
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation in gemistocytic astrocytomas.
Kösel S; Scheithauer BW; Graeber MB
Neurosurgery; 2001 Jan; 48(1):187-93; discussion 193-4. PubMed ID: 11152345
[TBL] [Abstract][Full Text] [Related]
7. The significance of gemistocytes in astrocytoma.
Yang HJ; Kim JE; Paek SH; Chi JG; Jung HW; Kim DG
Acta Neurochir (Wien); 2003 Dec; 145(12):1097-103; discussion 1103. PubMed ID: 14663567
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.
Ohta T; Kim YH; Oh JE; Satomi K; Nonoguchi N; Keyvani K; Pierscianek D; Sure U; Mittelbronn M; Paulus W; Vital A; Yokoo H; McDonald K; Kleihues P; Nazaret N; Barbet F; Lachuer J; Ohgaki H
J Neuropathol Exp Neurol; 2014 Oct; 73(10):908-15. PubMed ID: 25192052
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis of gemistocytic cells in gliomas.
Kros JM; Waarsenburg N; Hayes DP; Hop WC; van Dekken H
J Neuropathol Exp Neurol; 2000 Aug; 59(8):679-86. PubMed ID: 10952058
[TBL] [Abstract][Full Text] [Related]
10. Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective.
Tihan T; Vohra P; Berger MS; Keles GE
J Neurooncol; 2006 Jan; 76(2):175-83. PubMed ID: 16132490
[TBL] [Abstract][Full Text] [Related]
11. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
12. Gemistocytic astrocytomas: a reappraisal.
Krouwer HG; Davis RL; Silver P; Prados M
J Neurosurg; 1991 Mar; 74(3):399-406. PubMed ID: 1993905
[TBL] [Abstract][Full Text] [Related]
13. Gemistocytes in astrocytomas: are they a significant prognostic factor?
Martins DC; Malheiros SM; Santiago LH; Stávale JN
J Neurooncol; 2006 Oct; 80(1):49-55. PubMed ID: 16645716
[TBL] [Abstract][Full Text] [Related]
14. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
Ohgaki H; Kleihues P
J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
[TBL] [Abstract][Full Text] [Related]
15. [Gemistocytic astrocytomas].
Matsko DE; Zrelov AA; Ulitin AY; Matsko MV; Skliar SS; Baksheeva AO; Imyanitov EN
Arkh Patol; 2018; 80(4):27-38. PubMed ID: 30059069
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
[TBL] [Abstract][Full Text] [Related]
17. Microglia in gemistocytic astrocytomas.
Geranmayeh F; Scheithauer BW; Spitzer C; Meyer FB; Svensson-Engwall AC; Graeber MB
Neurosurgery; 2007 Jan; 60(1):159-66; discussion 166. PubMed ID: 17228265
[TBL] [Abstract][Full Text] [Related]
18. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
[TBL] [Abstract][Full Text] [Related]
19. Proliferation of gemistocytic cells and glial fibrillary acidic protein (GFAP)-positive oligodendroglial cells in gliomas: a MIB-1/GFAP double labeling study.
Kros JM; Schouten WC; Janssen PJ; van der Kwast TH
Acta Neuropathol; 1996; 91(1):99-103. PubMed ID: 8773153
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
